The global veterinary antibiotics market is anticipated to be worth US$ 11,453.3 million in 2023. The veterinary antibiotics market is expected to expand at a sluggish CAGR of 5.8% and reach US$ 20,154.0 million by 2033.
The expanding animal healthcare industry, combined with the industry's ongoing innovation, is driving growth in the veterinary antibiotics market. Tetracycline is anticipated to hold a leading market share in the global demand for veterinary antibiotics based on product type. This is due to its widespread application in animals used for food production.
Additionally, the demand for veterinary antibiotics is facilitated by people's increased knowledge of how critical providing basic medical care for their pets is. The prevalence of zoonotic diseases and the implementation of legislation intended to stop the spread of animal diseases are just a few factors that have contributed significantly to the growth of the veterinary antibiotics market.
The growth of this market is anticipated to be further propelled by rising expenditures on animal healthcare, as well as increasing demand for pet insurance. It is anticipated that in the coming years, the untapped emerging markets such as China, India, and Brazil, as well as growth in the overall companion animal population, are expected to offer significant growth opportunities to the veterinary antibiotics market players.
| Attribute | Details |
|---|---|
| Veterinary Antibiotics Market Share (2022) | US$ 10,911.5 million |
| Veterinary Antibiotics Market Share (2023) | US$ 11,453.3 million |
| Veterinary Antibiotics Market Share (2033) | US$ 20,154.0 million |
| Veterinary Antibiotics Market Share (2023 to 2033) | 5.8% |
On the other hand, only a limited amount of new antibiotics are being developed, there is a growing resistance to antimicrobials and antibiotics, and there is an increasing focus on good husbandry and hygiene practices. All of these factors are expected to impede the growth of the veterinary antibiotics market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Drivers:
It is anticipated that factors such as rising awareness about zoonotic disease, rising incidence of disease outbreaks in animals, and rising demand for food products derived from animals, promoting the veterinary antibiotics market share.
Moreover, the implementation of stringent regulations to prevent animal diseases, elevating the animal population, and increasing pet adoption are likely to drive the demand for veterinary antibiotics across the globe.
The sales of veterinary antibiotics are being driven upwards on a global scale by several factors, including the expanding market for pet health insurance and the rising cost of medical care.
Restraints:
In livestock, the spread of antibiotic-resistant microorganisms is a key concern. Pathogens found in food-producing animals can be transmitted to humans by direct contact between humans and animals or through the food chain and environmental exposure. An increase in people are dying as a result of antimicrobial-resistant diseases in the human population.
According to the World Health Organization, more than one-third of food-borne illness-related deaths occur in children under the age of five. Microbes, such as bacteria, are to blame for the majority of food-borne infections.
Infections caused by bacteria that are resistant to more than one class of antibiotics are becoming increasingly difficult to cure. As a result, veterinarians advise treating animals with lower concentrations of antibiotics.
As a result of these measures, antibiotic use around the world may be greatly reduced. This is expected to restrain the veterinary antibiotics market.
Opportunities:
Reduced anxiety, normalized blood pressure, fewer cardiac arrhythmias, and increased psychological well-being are all linked to the adoption of companion animals. These advantages have helped pet owners worldwide.
Since 2014, the United States dog population has grown from 77.8 million to 89.4 million, and the cat population has grown from 85.8 million to 95.6 million. The growth of allied sectors, such as animal antimicrobials and antibiotics, is anticipated to boost the need for veterinary antibiotics as pet owners' desire to invest in the health and well-being of their pets increases.
Threats:
An antimicrobial or an antibiotic is used to improve the health and productivity of livestock and companion animals. For the sake of animal health and efficacy, numerous authorities have established strict rules to approve animal pharmaceutical goods.
Veterinarian pharmaceutical products must meet rigorous standards set by these regulatory agencies before they may be approved. New veterinary pharmaceutical products, such as antimicrobials, vaccinations, parasiticides, and other pharmaceutical goods, are subject to strict regulatory criteria in countries such as Australia, Japan, and China.
Typically, it can take up to 11 years and cost 75 to 100 million dollars to have a veterinary drug approved in the United States and Europe (from product development to commercialization).
Additionally, it's understandable that the pharmaceutical industry is wary of investing in research and development of antimicrobial and antibiotic drugs to combat novel pathogens and parasite infections. This could be a huge challenge for the veterinary antibiotics market growth.
Principal Consultant
In 2022, 48.20% of the global veterinary antibiotics market for animals was made up of tetracyclines. Tetracyclines have many benefits, such as being the most effective against pathogenic microorganisms, being easily absorbed, having low toxicity, and being cheap compared to other antimicrobial and antibiotic products for animals.
Due to these benefits, this product segment has a large share of the veterinary antibiotics market. During the forecast period, the fluoroquinolones segment is expected to grow at a rate of 8%.
Fluoroquinolones are used more by end users as they work better at low concentrations, get into tissues quickly, and can be given in different ways.
In 2022, 46.10% of the global veterinary antibiotics market came from the premixes segment. The large share of this segment can be explained by the benefits of premixes, such as making it easier to give the medicine and less likely to change shape or absorb water.
During the period of the forecast, the injections segment is expected to have a substantial CAGR, at 4.9%. This veterinary antibiotic market share is expected to grow due to the benefits, like getting drugs right away and seeing their effects quickly.
Owing to the rising animal farming, rising expenditures on animal healthcare, and rising demand for food products derived from animals, North America held the dominant revenue share of 35.6% in the global veterinary antibiotics market in 2022. This was due to the region's growing demand for animal food products.
According to a report published by the FDA in 2014, over 80% of all antibiotics sold in the United States were purchased for application in animal husbandry. According to the same source, the overall quantity of antibiotics administered to animals used for the production of food in the United States climbed by 16.1% between 2009 and 2012, reaching a total of 14.61 million kilos annually.
During the forecast period, the Asia Pacific region is expected to increase at a CAGR of 5.4%. The APAC market for animal-derived food is growing as a result of factors such as an expanding animal population and an increased demand for animal-derived food products.
Due to the expanding poultry, meat, and dairy consumption and increasing awareness of animal health in emerging nations like India, the Asia Pacific veterinary antibiotics market is expected to grow at a faster rate in the region.
The veterinary antibiotics market study shows that national dietary changes in India have been documented. Meat intake among the young urban population has increased significantly over the past few decades.
As a result of the rising demand for animal proteins, fish, poultry, and pigs are now routinely bred with antibiotics to boost growth. In addition, the OECD reports that China is the world's leading producer of pork, with about 31.3 kg/capita produced in 2016, ahead of chicken and beef.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Companies are increasingly partnering with other players to boost product innovation in the veterinary antibiotics industry. As the veterinary antibiotics industry becomes more competitive, new veterinary medications businesses are expanding into new markets and producing drugs by sharing their knowledge and expertise with other companies.
Growth in the veterinary antibiotics market is anticipated to be fueled by the rising use of pet insurance. The global pet insurance industry is virtually untouched, with exceptionally low penetration rates, giving a tremendous market opportunity for new startups to rise.
New companies are emerging in the veterinary antibiotics market and tapping the market potential.
The veterinary antibiotics market is seeing an increase in collaboration between players. The primary reason is that collaborations provide companies access to a greater range of products and a more diverse technology set. Antibiotics generated as a result of this cooperation are of higher quality and manufactured faster.
Recent Developments Observed by FMI:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; The Middle East & Africa (MEA) |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, Nordic, Russia, BENELUX, Poland, France, Spain, Italy, Czech Republic, Hungary, Rest of EMEAI, Brazil, Peru, Argentina, Mexico, South Africa, Northern Africa, GCC Countries, China, Japan, South Korea, India, ASEAN, Thailand, Malaysia, Indonesia, Australia, New Zealand, Others |
| Key Segments Covered | Product Type, Route of Administration, Animal Type, Region |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The market is valued at US$ 11.4 billion in 2023.
Zoetis Inc., Merck & Co., and Bayer AG are the top market players.
The market is forecast to register a CAGR of 5.8% through 2033.
The Tetracyclines segment is likely to remain preferred through 2033.
Increasing awareness about the zoonotic disease is encouraging sales.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Tetracyclines
5.3.2. Penicillins
5.3.3. Macrolides
5.3.4. Sulphonamides
5.3.5. Aminoglycosides
5.3.6. Others
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033
6.3.1. Premixes
6.3.2. Injections
6.3.3. Oral Powders
6.3.4. Oral Solutions
6.3.5. Others
6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis by Animal Type, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by Animal Type, 2023 to 2033
7.3.1. Food-producing Animals
7.3.2. Companion Animals
7.4. Y-o-Y Growth Trend Analysis by Animal Type, 2018 to 2022
7.5. Absolute $ Opportunity Analysis by Animal Type, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Route of Administration
9.2.4. By Animal Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Route of Administration
9.3.4. By Animal Type
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Route of Administration
10.2.4. By Animal Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Route of Administration
10.3.4. By Animal Type
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product Type
11.2.3. By Route of Administration
11.2.4. By Animal Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Route of Administration
11.3.4. By Animal Type
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product Type
12.2.3. By Route of Administration
12.2.4. By Animal Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Route of Administration
12.3.4. By Animal Type
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product Type
13.2.3. By Route of Administration
13.2.4. By Animal Type
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Route of Administration
13.3.4. By Animal Type
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product Type
14.2.3. By Route of Administration
14.2.4. By Animal Type
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Route of Administration
14.3.4. By Animal Type
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Route of Administration
15.2.4. By Animal Type
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Route of Administration
15.3.4. By Animal Type
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Route of Administration
16.1.2.3. By Animal Type
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Route of Administration
16.2.2.3. By Animal Type
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Route of Administration
16.3.2.3. By Animal Type
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Route of Administration
16.4.2.3. By Animal Type
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Route of Administration
16.5.2.3. By Animal Type
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Route of Administration
16.6.2.3. By Animal Type
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Route of Administration
16.7.2.3. By Animal Type
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Route of Administration
16.8.2.3. By Animal Type
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Route of Administration
16.9.2.3. By Animal Type
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Route of Administration
16.10.2.3. By Animal Type
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Route of Administration
16.11.2.3. By Animal Type
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Route of Administration
16.12.2.3. By Animal Type
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Route of Administration
16.13.2.3. By Animal Type
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Route of Administration
16.14.2.3. By Animal Type
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Route of Administration
16.15.2.3. By Animal Type
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Route of Administration
16.16.2.3. By Animal Type
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Route of Administration
16.17.2.3. By Animal Type
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Route of Administration
16.18.2.3. By Animal Type
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Route of Administration
16.19.2.3. By Animal Type
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Route of Administration
16.20.2.3. By Animal Type
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Route of Administration
16.21.2.3. By Animal Type
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Route of Administration
16.22.2.3. By Animal Type
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product Type
16.23.2.2. By Route of Administration
16.23.2.3. By Animal Type
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Route of Administration
17.3.4. By Animal Type
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Zoetis, Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Merck & Co.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Bayer AG
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Sanofi
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Eli Lilly and Company
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Ceva Sante Animale
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Elanco Animal Health
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Virbac
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. HIPRA
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Lutim Pharma
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Veterinary Antibiotics Market
